Showing results (191-200 of 201) with videos related to
Sort By:
Pageof 21
Studies in Health Technology and Informatics|December 8, 1996
Virtual reality environments for psycho-neuro-physiological assessment and rehabilitationG Riva, M Bolzoni, F Carella, et al.Neurology|July 1, 2020
Deep brain stimulation in early-stage Parkinson disease: Five-year outcomesMallory L Hacker, Maxim Turchan, Lauren E Heusinkveld, et al.Memorias Do Instituto Oswaldo Cruz|October 25, 2008
Phlebotominae (Diptera: Psycodidae) fauna in the Chaco region and Cutaneous Leishmaniasis transmission patterns in ArgentinaOscar D Salomón, Juan R Rosa, Marina Stein, et al.Journal of Parkinson'S Disease|August 14, 2013
Pilot study assessing the feasibility of applying bilateral subthalamic nucleus deep brain stimulation in very early stage Parkinson's disease: study design and rationaleDavid Charles, Christopher Tolleson, Thomas L Davis, et al.Journal of Parkinson'S Disease|January 24, 2015
Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trialMichael G Tramontana, Anna L Molinari, Peter E Konrad, et al.Journal of Parkinson'S Disease|March 12, 2016
Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's DiseaseMallory L Hacker, Amanda D Currie, Anna L Molinari, et al.Parkinsonism & Related Disorders|April 29, 2014
Subthalamic nucleus deep brain stimulation in early stage Parkinson's diseaseDavid Charles, Peter E Konrad, Joseph S Neimat, et al.Neurology|July 1, 2018
Effects of deep brain stimulation on rest tremor progression in early stage Parkinson diseaseMallory L Hacker, Mahlon R DeLong, Maxim Turchan, et al.Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 5, 2004
Low energy proton irradiation effects on alveolar macrophages from young and aged ratsD R Tasat, R Mancuso, B L Molinari, et al.Blood Cancer Journal|November 10, 2018
Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trialsA Castellino, A Chiappella, B R LaPlant, et al.Pageof 21